Could Ginkgo’s OpenAI collab accelerate progress in longevity?
Ginkgo Bioworks and OpenAI demonstrated a GPT-5–powered autonomous lab that executed over 36,000 cell-free protein synthesis experiments with minimal human oversight. The preprint reports roughly 40% lower protein production costs and suggests such automation could accelerate longevity R&D by increasing experimental throughput, though results remain unpeer-reviewed.
Why it mattersGPT-5 driven autonomous labs reduced protein costs ~40%, so redirect R&D funding toward automated experimental platforms.